microdosing retatrutide Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and What Is Microdosing GLP-1s, and

These results were again contradicted by Murthy et al

Two common polymorphisms C677T (rs1801133) and A1298C (rs1801131) reduce enzyme activity, leading to elevated homocysteine and impaired methylation

But retatrutide may be even more effective , for several reasons: Glucagon receptor activation promotes hepatic fat oxidation Reduces liver fat accumulation more robustly Improves liver enzyme levels (ALT, AST) In a subgroup analysis of the retatrutide Phase 2 trial: Patients with suspected NAFLD showed a 70%+ reduction in liver fat content , measured by MRI-PDFF These effects surpassed the reductions seen with tirzepatide and semaglutide in comparable studies Another study showed that 93% of patients on the highest dose of retatrutide had 100% resolution of fatty liver

doi: 10.1126/scitranslmed.3003276 67 DengYQiHMaYLiuSZhaoMGuoZet al

GLP #1 is the generic form of FDA-approved GLP-1 medication